Mark Smyth, PhD is a senior scientist and immunology coordinator at QIMR Berghofer Medical Research Institute in Australia. He is a leading expert in cancer immune surveillance and defined immune-mediated cancer dormancy. He has pioneered new methods for classifying natural killer cell subtypes. Mark is a past winner of the Copley Medal and Charles Rodolphe Brupbacher Prize in cancer research, and is the highest cited immunologist in Australia. He is a senior editor with Cancer Immunology Research and an advisory board member with Science.
Mark earned his PhD from the University of Melbourne.